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OBJECTIVE — It has been argued that the relationship between depression and diabetes is
bi-directional,butthishypothesishasnotbeenexplicitlytested.Thissystematicreviewexamines
the bi-directional prospective relationships between depression and type 2 diabetes.
RESEARCH DESIGN AND METHODS — A search was conducted using Medline for
publications from 1950 through 2007. Reviewers assessed the eligibility of each report by
exposure/outcome measurement and study design. Only comparative prospective studies of
depression and type 2 diabetes that excluded prevalent cases of depression (for diabetes pre-
dicting depression) or diabetes (for depression predicting diabetes) were included. Two sets of
pooledriskestimateswerecalculatedusingrandomeffects:depressionpredictingtype2diabetes
and type 2 diabetes predicting depression.
RESULTS — Of 42 full-text publications reviewed, 13 met eligibility for depression predict-
ing onset of diabetes, representing 6,916 incident cases. Seven met criteria for diabetes predict-
ing onset of depression, representing 6,414 incident cases. The pooled relative risk (RR) for
incident depression associated with baseline diabetes was 1.15 (95% CI 1.02–1.30). The RR for
incident diabetes associated with baseline depression was 1.60 (1.37–1.88).
CONCLUSIONS — Depression is associated with a 60% increased risk of type 2 diabetes.
Type 2 diabetes is associated with only modest increased risk of depression. Future research
should focus on identifying mechanisms linking these conditions.
Diabetes Care 31:2383–2390, 2008
D
epression and diabetes are highly
prevalent in the U.S. Over 6.5% of
the U.S. adult population has been
diagnosed with diabetes (1), and the inci-
dence of type 2 diabetes is increasing, in
part due to the national increase in obe-
sity. Approximately 16% of U.S. adults
will suffer major depressive disorder at
some point in their lives, and this propor-
tion is greater when other forms of de-
pressive disorder, such as dysthymia and
minordepression,areincluded(2).Thus,
thehypothesisthatdepressionanddiabe-
tes are causally related deserves attention
fromresearchersandpolicy-makersalike.
Depression is associated with poor
health behaviors (i.e., smoking, physical
inactivity, caloric intake) that increase
risk of type 2 diabetes (3). Depression is
also related to central obesity and poten-
tially to impaired glucose tolerance (4).
Depression is associated with physiologi-
cal abnormalities, including activation of
the hypothalamic-pituitary-adrenal axis,
sympathoadrenal system, and pro-
inﬂammatory cytokines, which can in-
duce insulin resistance and contribute to
diabetes risk (5). Diabetes may increase
risk of depression because of the sense of
threat and loss associated with receiving
this diagnosis and the substantial lifestyle
changes necessary to avoid developing
debilitating complications. Also, studies
suggest that late-life depression is associ-
ated with a history of vascular disease, in-
cluding diabetes (6). In sum, evidence
suggests that the exposure/outcome rela-
tionship between these conditions is bi-
directional and may change over the life
course.
Previous reviews have explored the
relationship between depression and dia-
betesusingretrospective(7)andprospec-
tive (8) studies, but none have assessed
this relationship from a lifespan perspec-
tive by simultaneously examining its bi-
directionality. Retrospective studies often
uselifetimeprevalencemeasuresandthus
theydonotinformquestionsoftemporal-
ity. The search criteria used in previous
reviews have been relatively conservative
and may have missed studies in which
depression or diabetes was not the pri-
maryexposureofinterest.Whilebothde-
pression and diabetes are more common
among certain demographic groups (i.e.,
women and African Americans, respec-
tively), it is unclear whether this relation-
ship varies across such groups. We
therefore undertook a new review to syn-
thesize the current evidence of the pro-
spective relationships between
depression and type 2 diabetes and pro-
vide a more reliable risk estimate and
comprehensive picture of these relation-
ships over the lifespan.
RESEARCH DESIGN AND
METHODS
Search strategy
We conducted literature searches using
MEDLINE with the three limits “publica-
tion date from 1 January 1950 to 31 De-
cember 2007,” “English language,” and
“human subjects” and combinations of
the medical subject headings “Diabetes
Mellitus” or “Diabetes Mellitus, Type 2,”
“Depression” or “Depressive Disorder,”
“Risk Factors,” and “Prospective Studies”
or “Longitudinal Studies.” The reference
lists of previous meta-analyses and se-
lected articles were screened.
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To be included, a report had to 1) have a
prospective design, 2) include cases of
probable type 2 diabetes (i.e., studies that
examinedonlytype1diabetesordiabetes
before age 30 years were excluded), 3)
provideenoughdatatogeneratearelative
risk estimate, and 4) exclude prevalent
cases of either depression (for diabetes
predicting depression onset) or diabetes
(for depression predicting diabetes on-
set).Intheeventofmultiplepublications,
onlythemostrecentmanuscriptforapar-
ticular study population was included.
Data extraction
Two reviewers used a custom data ab-
straction form to evaluate and summarize
selected articles. Abstracted information
included authors, year, location, source
of participants, sample composition, as-
sessment of diabetes/depression, and
matchingand/orstatisticaladjustmentfor
potential confounders. If multiple risk es-
timates (with error measurements) were
presented in a given manuscript (e.g.,
nested multivariable models), the esti-
mate that most closely adjusted for only
demographic characteristics (e.g., age,
sex, race, socioeconomic indicators, and
marital status/household composition)
was selected. We chose this approach be-
cause some studies adjusted for promi-
nent effect modiﬁers (i.e., family history,
health behaviors, adiposity) while others
did not, and thus the interpretation of the
Table 1—Comparative prospective studies of depression and incident type 2 diabetes
Author Follow-up
Incident n/
Total n Sample source
Sample
composition*
Eaton et al. (17) 13 years 89/1,920 Population based Age: 18 years
63% F
34% B
Kawakami et al. (26) 8 years 41/2,380 Occupation based Age: 18 years
Only men
100% A
Stellato et al. (21) 9 years 54/1,156 Population based Age: 40–70 years
Only men
97% W
Carnethon et al. (18) 15.6 years 369/6,190 Population based Age: 25–74 years
59% F
15% B
Arroyo et al. (14) 4 years 973/72,178 Occupation based Age: 45–72 years
Only women
100% W
Everson-Rose et al. (19) 3 years 96/2,662 Population based Age: 42–52 years
Only women
47% W
Golden et al. (22) 6 years 721/11,615 Population based Age: 48–67 years
56% F
22% B
Kumari et al. (27) 10.5 years 361/10,308 Occupation based Age: 35–55 years
44% F
95% W
Palinkas et al. (28) 8 years 79/971 Population based Age: 50 years
57% F
100% W
van den Akker et al. (20) 15 years 3,245/68,004 Clinic network Age: 20 years
58% F
Mallon et al. (23) 12 years 88/2,663 Population based Age: 45–65 years
53% F
Carnethon et al. (24) 8 years 147/4,681 Population based Age: 65 years
59% F
13% B
Engum (25) 10 years 653/37,291 Population based Age: 30 years
55% F
*Racial/ethniccompositionnotprovidedforsomestudies:A,Asian;B,AfricanAmerican;F,female;W,non-Hispanicwhite.BDI,BeckDepressionInventory;CES-D,
Centers for Epidemiologic Studies Depression Scale; FPG, fasting plasma glucose; MRD, medical record diagnosis; OGTT, 75-g oral glucose tolerance test; SHBG,
sex hormone–binding globulin. †Selected estimate refers to estimate that is most closely adjusted for only demographic characteristics (age, sex, race/ethnicity,
socioeconomicindicators,andmaritalstatus)andistheestimateusedinthepooledanalysesandaredepictedinFigure1.EstimatesforMallonetal.(23)andKumari
et al. (24) derived from pooled random-effects models across sex.
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timates from each study is misleading, for
it is neither an estimate of the direct nor
the total effect (9).
Statistical analysis
The estimate from each study was used to
generate a pooled relative risk using ran-
dom effects. Two separate analyses were
conducted: depression predicting type 2
diabetes and type 2 diabetes predicting de-
pression. Random-effects modeling explic-
itly accounts for unmeasured variability
across the values using the DerSimonian
and Laird method, resulting in a pooled
estimate with a wider conﬁdence interval
relativetotheﬁxed-effectsmodels(10).We
evaluatedheterogeneityintheestimatesus-
ing the Cochrane Q statistic. If a study only
presented stratiﬁed risk estimates (i.e., by
sex), these estimates were combined using
random effects and then that pooled esti-
mate was used for the meta-analysis. For
studies that presented graded relationships
(e.g., low, medium, high depressive symp-
toms), only the estimate for the highest cat-
egory was selected. Forest plots of the
estimates and 95% CIs, with the weight of
eachpointestimateindicatedbytherelative
sizeofthemarker,wereusedtovisualizethe
rangeofeffects.Weusedsubgroupanalyses
to explore potential variability in the rela-
tionships by demographic characteristics
(e.g.,age,sex,race)andconductedsensitiv-
ity analyses to assess the robustness of our
results (11). We used Egger’s test and fun-
nel plots to assess publication bias. If such
bias was evident, we used the trim and ﬁll
approach(12)togenerateapooledestimate
that accounted for the unpublished nega-
tive ﬁndings. All analyses were conducted
using Stata v9.0 (StataCorp, College Sta-
tion,TX),andstatisticalsigniﬁcancewasset
a priori at P  0.05.
RESULTS
Study selection
Atotalof21,190original-researcharticles
were retrieved by the searches (the titles
of which were examined by two indepen-
dent reviewers). Manuscripts that did not
reference either depression or diabetes in
the title (or speciﬁcally referred to type 1
Table 1—Continued
Depression assessment Diabetes assessment
Selected estimate
(95% CI)†
Statistical adjustment for selected
estimate†
Diagnostic Interview Schedule Self-report 2.23 (0.90–5.55) Age, sex, race, and BMI
Zung Self-Report Depression Scale OGTT 2.32 (1.06–5.08) Age
CES-D Self-report 3.09 (1.34–7.12) Free testosterone, SHBG, hypertension,
heart disease, and BMI
General Well-Being Scale Self-report, MRD, death 2.52 (1.73–3.67) Age, race, and sex
certiﬁcate
Short-Form 36 Self-report 1.55 (1.27–1.90) Age
CES-D Self-report, FPG 1.66 (1.05–2.61) Age, study site, race, education, and
medication use
Vital Exhaustion Questionnaire Self-report, FSG 1.63 (1.31–2.02) Age, sex, race, study site, and
education
General Health Questionnaire Self-report, OGTT 1.14 (0.83–1.57) Age, sex, length of follow-up, ethnicity,
electrocardiogram abnormalities,
and employment grade
BDI OGTT, FPG, non-FPG 2.50 (1.29–4.87) Age, sex, physical activity, and BMI
International Classiﬁcation of Health Problems MRD 1.04 (0.84–1.28) Age, sex, BMI, socioeconomic status,
in Primary Care (ICHPPC-2) and interaction of
depression*age*sex
Self-reported dysphoria Self-report 1.47 (0.48–4.47) Age
CES-D Diabetes medication 1.63 (1.12–2.36) Age, race, and sex
use or FPG
Anxiety and Depression Index Self-report, conﬁrmed 1.51 (1.27–1.80) Age, sex, education, and marital status
with FPG
Mezuk and Associates
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titles that referred to “development,”
“risk/incidence,” or “comorbidity/co-
occurrence” and similar terms were se-
lected for additional review (n  1,168).
From this set, 42 articles were retrieved
for full abstraction. Of these, 24 articles
did not meet selection criteria and were
excluded (see Supplemental Fig. 1 and
supplemental search results in the online
appendix available at http://dx.doi.org/
10.2337/dc08-0985). Ten studies were
excluded for failing to remove prevalent
cases of depression/diabetes at baseline.
One was excluded for using a measure of
“burnout” rather than depression. Ten re-
ports were excluded because they did not
provide enough data to generate a risk
estimate. Two studies used the same sam-
ple (13,14), and only the most recent
publication (Arroyo et al. [14]) was re-
tained.Twostudiesusedsamplesselected
forthepresenceofspeciﬁcdiabetesorde-
pression risk factors (antipsychotic med-
ications [15] and coronary heart failure
[16]), respectively). We determined that
these samples would introduce bias and
heterogeneity into the pooled estimate
and therefore excluded them. However,
we conducted sensitivity analyses to as-
sess the effect of this decision. The re-
maining 18 articles (two of which
examined both depression predicting di-
abetes and diabetes predicting depres-
sion) were retained for analysis and are
described in Tables 1 and 2.
Depression predicting type 2
diabetes
The results from 13 studies of depression
predictingincidentdiabetes,representing
6,916 cases of diabetes, are consistent
(Fig. 1A). Even in those instances in
which the association was not statistically
signiﬁcant, the trend for depression to in-
crease risk of subsequent diabetes was
present. Assessment of heterogeneity in-
dicatedthattherandomeffectsmodelwas
appropriate (Cochrane Q statistic [13
d.f.]: 37.63, P  0.001), generating a
pooled relative risk (RR) of 1.60 (95% CI
1.37–1.88).
Measurement of depression and dia-
betes status varied across the reports.
Most used nondiagnostic measures of
depressive symptoms and distress (i.e.,
Centers for Epidemiologic Studies for
Depression Scale, General Health Ques-
tionnaire). Several studies supplemented
self-report measures of diabetes with
physiologic measures (i.e., fasting plasma
glucose). The consistency of this relation-
ship across different means of depression
anddiabetesassessmentindicatesthatthe
ﬁnding is unlikely to be a spurious result
of measurement error.
Type 2 diabetes predicting
depression
Only seven studies investigated the asso-
ciation between type 2 diabetes and risk
of depression (Table 2), representing
6,414 incident cases (Fig. 1B). There was
no evidence of heterogeneity (Q statistic
[6 d.f.]: 9.17, P  0.16); however, we
Figure 1—Forest plot of prospective studies of depression and type 2 diabetes. A: Baseline depression predicting incident type 2 diabetes. B: Base-
line diabetes predicting incident depression.
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consistent with the above analyses (the
ﬁxed-effects estimates did not differ sub-
stantially or change the interpretation of
the ﬁndings; data not shown). There is
only modest evidence to support the hy-
pothesis that type 2 diabetes is a “depres-
sogenic” condition that increases risk
developing depression (RR 1.15, 95% CI
1.02–1.30).
Moderating inﬂuences
We conducted a series of random effects
subgroupanalysestoexplorewhetherthe
relation for depression predicting diabe-
tes varied across demographic groups.
The RR from studies that reported a mean
(or median) age of 50 years (17–19) or
that provided age-stratiﬁed results (20)
was 1.96 (P  0.001), while the RR de-
rived from studies with mean/median age
50 years (14,21–25) or that provide
age-stratiﬁed results was more modest
(RR1.50,P0.001)(twostudies[26,27]
did not provide mean/median age). The
RR for women (derived only from six
studies that excluded men [14,19] or
provided sex-stratiﬁed estimates
[20,23,25,27]) was 1.26 (95% CI 0.95–
1.67). The RR for men (derived from six
studies that excluded women (21,26) or
provided sex-stratiﬁed estimates) was
1.57 (1.24–1.99). The RR for studies that
included primarily (95%) whites
(14,21,27,28) was 1.65 (P  0.004). The
RR for studies that included at least 10%
African Americans (17–19,22,24) was
similar(RR1.79,P0.001)(fourstudies
that either did not report racial/ethnic
composition [20,23,25] or included only
Asians [26] were excluded).
Sensitivity analysis
We conducted a series of sensitivity anal-
yses to assess the robustness of our ﬁnd-
ings. First, we assessed the inﬂuence of
selecting the demographic-adjusted esti-
mate for the main analyses by pooling es-
timates from the most- and least-adjusted
models across the studies. For studies of
depression predicting diabetes, the least-
adjusted RR was 1.61 (95% CI 1.38–
1.88), and the most-adjusted (all 13 of
whichadjustedforadiposity)RRwas1.40
(1.21–1.61). For diabetes-predicting de-
pression, the least-adjusted pooled RR
was 1.20 (1.06–1.36) and the most-
adjusted (only two of which adjusted for
adiposity) RR was 1.09 (1.01–1.18). Sec-
ond, we assessed the impact of excluding
the Miller et al. (15) and Havranek et al.
(16) studies (excluded because of sample
selection criteria, described above). For
depression predicting diabetes, inclusion
of the antipsychotic medication use sam-
ple (15) slightly attenuated the pooled es-
timate (RR 1.54, P  0.001). For
diabetes-predicting depression, inclusion
of the heart failure sample (16) did not
alter the pooled estimate (RR 1.17, P 
0.012).Weconductedanalysesexcluding
studiesthatdidnotadjustforage(21,29),
which slightly attenuated both sets of re-
sults (data not shown). For depression
predicting diabetes, studies that used
physiologic testing or clinical records to
supplement diabetes measurement re-
ported slightly smaller effects (RR 1.58)
than those that relied only on self-report
(RR 1.63), although both were statisti-
cally signiﬁcant (P  0.001). Similarly,
for diabetes-predicting depression, stud-
ies with clinical measures reported
smaller effects (RR 1.11) than self-report
only (RR 1.16), but these results were no
longer statistically signiﬁcant (P  0.26).
Finally, because both depression and di-
abetes can have extended prodromal pe-
riods, we excluded four samples that had
short (5 years) follow-up periods
(14,19,29,30). After excluding these
studies, diabetes was no longer a signiﬁ-
cant predictor of depression (RR 1.09,
95% CI 0.96–1.25), but depression re-
mained predictive of incident diabetes
(1.64, 1.34–2.00).
Assessment of publication bias
We found suggestive but not statistically
signiﬁcant evidence of publication bias
for studies of depression predicting dia-
betes (Begg’s corrected rank coefﬁcient
1.40, P  0.161, and Egger’s test, P 
0.089) (Fig. 2) consistent with a previous
meta-analysis (8). Using the ﬁll and trim
approach (12), which imputes estimates
from hypothetical negative unpublished
reports, the publication-bias corrected
Figure2—Begg’sfunnelplotwith95%conﬁdencelimits.A:Depressionpredictingincidentoftype
2 diabetes. B: Type 2 diabetes predicting incident depression.
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icant (RR 1.42, 95% CI 1.20–1.67).
There was no evidence, either from visual
inspection of the funnel plot or the Begg’s
coefﬁcient(0.30,P0.76)ofpublication
bias regarding studies of diabetes-
predicting depression.
CONCLUSIONS — There is a strong
and robust association between depres-
sion and incidence of type 2 diabetes, but
onlyaweakrelationbetweendiabetesand
risk of depression. Early retrospective
studies had suggested that the relation-
ship between depression and diabetes
was bi-directional, but prospective analy-
ses were necessary to understand its nat-
ural history. In contrast to the reports of
depression predicting diabetes, there was
no evidence of heterogeneity or modera-
tion of effect among the studies of diabe-
tes predicting depression. Diabetes is a
serious metabolic disorder that has life-
changing consequences for individuals
affected by it. Depression is a complex
condition characterized by disruptions in
all facets of life—social, psychological,
behavioral, and biological. The ﬁnding
that depression is associated with a 60%
increase in risk of developing type 2 dia-
betes rivals other known risk factors for
this disease, such as smoking (31). Our
ﬁndings suggest that there is only a mod-
est association between diabetes and inci-
dence of depression, but it is an
understudied phenomenon, and it may
be that competing risks for late-life de-
pression (i.e., macrovascular disease,
functional/cognitive decline) mask this
relationship.Depressionisalsodifﬁcultto
detect in older adults (32), and thus mea-
surement error may partially explain why
this association is so modest. The sub-
group analyses suggest this relationship
may vary by age and sex, and studies
should focus on identifying groups in
which this association is particularly ro-
bust to target prevention efforts.
Risk factor epidemiology can inform
prioritization of prevention efforts
through the notion of population-
attributable risk (33). The population-
attributable risk describes the magnitude
of reduction in a given outcome expected
if the effect of the risk factor were elimi-
nated, assuming the risk factor is a neces-
sary cause of the outcome. It is a function
of the strength of the association and the
prevalenceoftheriskfactor.Forexample,
atypical antipsychotic medications are as-
sociated with 30% increased risk of
type 2 diabetes (15), but use of these
agents is rare in the general population
(prevalence 1%), and thus the associ-
atedpopulation-attributableriskisonthe
order of 0.5%. In contrast, the risk for
diabetes associated with depression re-
ported above coupled with a prevalence
of 16% (2) is associated with a popula-
tion-attributable risk of 9% because
depression is much more common.
This analysis has strengths and limi-
tations. The primary strengths are the ex-
pansive literature search and the explicit
assessment of the bi-directionality of the
depression-diabetes relationship, which
previous reviews have not systematically
evaluated. We also conducted sensitivity
analyses to assess the robustness of our
ﬁndings. The primary limitation stems
from the quality of the included studies.
There was evidence of heterogeneity and
potential publication bias among the
studies of depression predicting diabetes,
andwhileweconductedarelativelybroad
search,bylimitingittoonlyonedatabase,
we may have missed some reports. How-
ever, inclusion of the hypothetical miss-
ing negative studies still resulted in a
statistically signiﬁcant, albeit attenuated,
pooled estimate of elevated risk of diabe-
tes. Importantly, even this attenuated risk
estimate was of greater magnitude than
the pooled risk estimate of diabetes pre-
dicting depression. While we attempted
to generate the total effect of the depres-
sion-diabetes relationship by selecting
estimates adjusted primarily for demo-
graphic characteristics, adjustment for
confounders varied, and thus our pooled
analysesonlyapproximatethetotaleffect.
We did not examine the role of diabetes
complications in this analysis, although
there is compelling evidence that depres-
sion is associated with poorer glycemic
control(34)andincreasedriskofcompli-
cations (35).
Research should move from epidemi-
ologicinvestigationsthathaveestablished
this association and begin the process of
empirically testing causal hypotheses.
Many aspects of this relationship—most
notably,whethertreatingdepressionlow-
ers the increased risk of diabetes—have
yet to be examined in a controlled man-
ner, although there is suggestive evidence
that antidepressant use is associated with
elevated, not lowered, risk of diabetes,
possibly an example of confounding by
indication (36). The studies reviewed
here demonstrate the importance of early
detectionofdepressionandtheimportant
role of primary care physicians in careful
monitoring of the physiological conse-
quences and correlates of psychiatric
disorders.
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